These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1804779)

  • 1. Transplantation of normal and leukemic human bone marrow into immune-deficient mice: development of animal models for human hematopoiesis.
    Dick JE; Lapidot T; Pflumio F
    Immunol Rev; 1991 Dec; 124():25-43. PubMed ID: 1804779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models for human hematopoiesis.
    Dick JE; Pflumio F; Lapidot T
    Semin Immunol; 1991 Nov; 3(6):367-78. PubMed ID: 1799667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis.
    Lapidot T; Fajerman Y; Kollet O
    J Mol Med (Berl); 1997 Sep; 75(9):664-73. PubMed ID: 9351705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines.
    Kollmann TR; Kim A; Zhuang X; Hachamovitch M; Goldstein H
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8032-6. PubMed ID: 7914701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-deficient mice as models of normal and leukemic human hematopoiesis.
    Dick JE
    Cancer Cells; 1991 Feb; 3(2):39-48. PubMed ID: 1851428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling human hematopoiesis in immunodeficient mice.
    Lapidot T; Pflumio F; Dick JE
    Lab Anim Sci; 1993 Apr; 43(2):147-50. PubMed ID: 8320962
    [No Abstract]   [Full Text] [Related]  

  • 8. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.
    Reinisch A; Thomas D; Corces MR; Zhang X; Gratzinger D; Hong WJ; Schallmoser K; Strunk D; Majeti R
    Nat Med; 2016 Jul; 22(7):812-21. PubMed ID: 27213817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AFT024 stromal cell line supports long-term ex vivo maintenance of engrafting multipotent human hematopoietic progenitors.
    Nolta JA; Thiemann FT; Arakawa-Hoyt J; Dao MA; Barsky LW; Moore KA; Lemischka IR; Crooks GM
    Leukemia; 2002 Mar; 16(3):352-61. PubMed ID: 11896538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal and leukemic human stem cells assayed in SCID mice.
    Dick JE
    Semin Immunol; 1996 Aug; 8(4):197-206. PubMed ID: 8883142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine models of normal and neoplastic human haematopoiesis.
    Dick JE; Sirard C; Pflumio F; Lapidot T
    Cancer Surv; 1992; 15():161-81. PubMed ID: 1451110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-deficient mice as models for human hematopoietic disease.
    Dick JE
    Mol Genet Med; 1991; 1():77-115. PubMed ID: 1688188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice.
    Lapidot T; Pflumio F; Doedens M; Murdoch B; Williams DE; Dick JE
    Science; 1992 Feb; 255(5048):1137-41. PubMed ID: 1372131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(3):144-54. PubMed ID: 10392960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
    Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
    Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation.
    Caselli A; Olson TS; Otsuru S; Chen X; Hofmann TJ; Nah HD; Grisendi G; Paolucci P; Dominici M; Horwitz EM
    Stem Cells; 2013 Oct; 31(10):2193-204. PubMed ID: 23818291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCID mice as an in vivo model of human cord blood hematopoiesis.
    Vormoor J; Lapidot T; Pflumio F; Risdon G; Patterson B; Broxmeyer HE; Dick JE
    Blood Cells; 1994; 20(2-3):316-20; discussion 320-2. PubMed ID: 7538337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.